Diabetic retinopathy : What’s new
Course organizers
Renu A Kowluru, PhD, FARVO, Wayne State University, Kresge Eye Institute and Arup Das, MD, PhD, University of New Mexico School of Medicine, NM VA Health Care System
Course description
This course will bring together clinicians and basic scientists in the field to address various aspects of diabetic retinopathy including systemic factors, genetic associations, molecular mechanisms, cell-cell interactions and novel imaging and drug delivery techniques. The course will provide an outstanding platform for the vision community to have a balanced discussion of the experimental and clinical aspects of diabetic retinopathy.
The content of this course is suitable for junior researchers seeking a foundational overview of the study and treatment of diabetic retinopathy and more seasoned basic and clinician scientists seeking to learn what is new in this area of research.
Estimated duration
4 hours and 30 minutes
Members-in-Training ($49.00); Members ($79.00); Nonmembers ($109.00)
Description
After attending this educational course, the participant will be able to:
- Summarize the molecular mechanisms of diabetic retinopathy, including experimental models, inflammation, epigenetics, and roles of lipids and microbiome.
- Outline the epidemiology, systemic factors and genetics of diabetic retinopathy.
- Explain the role of diagnostic studies and novel biomarkers in diabetic retinopathy.
- Evaluate the major clinical trials on anti-VEGF therapies in diabetic retinopathy.
- Describe the novel therapies including pharmacotherapies and cell-based therapy.
Presentations in package:
Results 1 - 10 of 11
| Title | Credit(s) | |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| 4 | ||
| 5 | ||
| 6 | ||
| 7 | ||
| 8 | ||
| 9 | ||
| 10 |
